Suppr超能文献

[甲状腺疾病中总血浆L-三碘甲状腺原氨酸与L-甲状腺素的不一致性]

[Discordance of total plasma l-triiodothyronine and l-thyroxine in thyroid diseases].

作者信息

Codaccioni J L, Gillioz P, Carayon P

出版信息

Ann Endocrinol (Paris). 1980 May-Jun;41(3):193-202.

PMID:7416706
Abstract

Radioimmunoassay (RIA) for plasma T3 has been proposed in the diagnosis of thyroid disease. 1 171 simultaneous determination (RIA) of plasma Thyrotropin-Stimulating Hormone (TSH), triiodothyronine (T3) and thyroxine (T4) have been performed in unselected patients under suspicion of a thyroid disease. 81.8% of the cases showed a good agreement between T3 and T4 levels. The remaining 18.2% can be divided into 6 groups: 1. High T3-normal T4 : 51% of the discrepancies: Graves disease untreated (16%) or treated (4%); sporadic goiter (13%); growth failure (8%); hypothyroidism under treatment (6%); thyroiditis, Graves ophtalmopathy, toxic adenoma (4%); 2. High T3-low T4 : 6.5%; sporadic goiter (3%); hypothyroidism (3%); 3. Normal T3-low T4 : 22%: Graves disease under treatment (6%); sporadic goiter (4.5%); subacute thyroiditis (3%); hypothyroidism (3%); miscellaneous (5.5%); 4. Normal T3-High T4 : 9.5%; thyroidectomized patients for cancer well-substituted with T4 (6%); miscellaneous (3.5%) including 1 case of Graves disease; 5. Low T3-normal T4 : 8% 8%: sporadic goiter (4%); hypothyroidism (2%); treated hyperthyroidism (2%); 6. Low T3-high T4 : 3% : including 1 case of hyperthyroidism and 2 cases of thyroidectomized patients well-substituted with T4. In conclusion discrepancies between T3 and T4 levels have been observed mainly in untreated or treated Graves disease (high T3-normal or low T4) and in hypothyroidism (normal or high T3-low T4). The basal TSH and TSH peak after I.V. injection of TRH (65 cases) are in better agreement with T4 level than with T3 level. Indeed, both TRS values are high when T4 is low while T3 is normal of high.

摘要

血浆三碘甲状腺原氨酸(T3)放射免疫测定法(RIA)已被用于甲状腺疾病的诊断。对1171例疑似甲状腺疾病的非选择性患者同时进行了血浆促甲状腺激素(TSH)、三碘甲状腺原氨酸(T3)和甲状腺素(T4)的测定(放射免疫测定法)。81.8%的病例T3和T4水平显示出良好的一致性。其余18.2%可分为6组:1. T3高-T4正常:占差异的51%:未治疗(16%)或已治疗(4%)的格雷夫斯病;散发性甲状腺肿(13%);生长发育迟缓(8%);治疗中的甲状腺功能减退(6%);甲状腺炎、格雷夫斯眼病、毒性腺瘤(4%);2. T3高-T4低:6.5%;散发性甲状腺肿(3%);甲状腺功能减退(3%);3. T3正常-T4低:22%:治疗中的格雷夫斯病(6%);散发性甲状腺肿(4.5%);亚急性甲状腺炎(3%);甲状腺功能减退(3%);其他(5.5%);4. T3正常-T4高:9.5%;因癌症接受甲状腺切除术且T4替代良好的患者(6%);其他(3.5%),包括1例格雷夫斯病;5. T3低-T4正常:8%:散发性甲状腺肿(4%);甲状腺功能减退(2%);治疗后的甲状腺功能亢进(2%);6. T3低-T4高:3%:包括1例甲状腺功能亢进和2例T4替代良好的甲状腺切除患者。总之,T3和T4水平的差异主要见于未治疗或已治疗的格雷夫斯病(T3高-T4正常或低)和甲状腺功能减退(T3正常或高-T4低)。静脉注射促甲状腺激素释放激素(TRH)后基础TSH及TSH峰值(65例)与T4水平的一致性比与T3水平更好。实际上,当T4低而T3正常或高时,两个TRS值均较高。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验